Fatty acids that selectively kill senescent cells open new paths for age-related therapies
New research from the University of Minnesota Medical School has identified fatty acids that selectively induce death in senescent cells—the culprits...
Romiplostim prevents serious side effect of chemotherapy in phase 3 trial
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the medication romiplostim can effectively prevent...
Evaluating the effects of hypnotics for insomnia in obstructive sleep apnea
Obstructive sleep apnea (OSA) is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse during sleep. This leads...
In a hyperconnected world, shared expectations can shape how negative experiences feel
Imagine waiting in line for a shot when someone who just got one tells you it was really painful. Could hearing that make the shot hurt more? According...
New data signals high demand in aesthetic surgery in southern, rural U.S. despite access issues
A new, national analysis published in the Aesthetic Surgery Journal suggests the future growth of aesthetic surgery may lie far from traditional luxury...
Super‑agers’ brains stay young into old age. New research brings us closer to understanding why
My grandmother Leontina, who recently turned 100, still lives independently and remembers the birthday of everybody in her village. She is enviably...
FDA provides fast track designation to nipocalimab for systemic lupus erythematosus
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with...
Why hot, polluted weeks may be a critical window for suicide prevention
Suicide rates in the U.S. have been steadily rising since the late 1990s, leading to an urgent need to understand what's putting people at risk. Risk...
A “mirror” molecule can starve cancer cells without harming healthy cells
Most cancer treatments attack rapidly dividing cells, but they often harm healthy cells as well. This damage can lead to serious side effects....
FDA provides fast track designation to nipocalimab for systemic lupus erythematosus
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with...
